Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
Jump to:
Preferred Name | asparaginase erwinia chrysanthemi | |
Synonyms |
|
|
ID |
http://purl.obolibrary.org/obo/dinto_DB08886 |
|
AHFScode |
10:00
|
|
ATCCode |
L01XX02
|
|
DBBrand |
erwinaze
|
|
DBSynonym |
erwinia chrysanthemi l-asparaginase (erwinia) asparaginase erwinia chrysanthemi
|
|
Definition |
Erwinaze (asparaginase Erwiniachryanthemi) contains an asparaginase specific enzyme derived from Erwiniachrysanthemi. L-asparaginase is a tetrameric enzyme consisting of four identical subunits, each having a molecular weight of about 35 kDa. The activity of Erwinaze is expressed in terms of International Units. It is an antineoplastic agent and was FDA approved in November 19, 2011.
|
|
label |
asparaginase erwinia chrysanthemi
|
|
prefixIRI |
obo2:dinto_DB08886
|
|
prefLabel |
asparaginase erwinia chrysanthemi
|
|
xref |
National Drug Code Directory:57902-249-05 Drugs.com:http://www.drugs.com/monograph/asparaginase-erwinia-chrysanthemi.html UniProtKB:P06608 Wikipedia:http://en.wikipedia.org/wiki/User:Riggs2/article_notes RxList:http://www.rxlist.com/erwinaze-drug.htm GenBank:X12746
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping